CCl3N3H6

CCl3N3H6, also known as hexamethylmelamine (HMM), is an organic compound with the chemical formula C7H15N3. It is a derivative of melamine, where the three amino groups of melamine are methylated. HMM is a white crystalline solid and is sparingly soluble in water.

Historically, hexamethylmelamine was investigated as an antineoplastic agent, meaning it was studied for its potential to treat cancer. It was developed by the United States National Cancer Institute (NCI) in the 1960s. Its mechanism of action is believed to involve alkylation of DNA, which interferes with cancer cell replication. Clinical trials were conducted, but its use in cancer therapy was ultimately limited due to toxicity and the development of more effective treatments.

Hexamethylmelamine has also been explored for other applications, though none have achieved widespread commercial success. Its chemical structure, with multiple nitrogen atoms and a stable ring system, suggests potential for use in coordination chemistry or as a precursor for other nitrogen-containing compounds. However, its primary historical significance remains its investigation as a chemotherapy drug.